Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Respiratory Research

Figure 1

From: Survival in severe alpha-1-antitrypsin deficiency (PiZZ)

Figure 1

Kaplan-Meier analysis of mortality stratified by mode of identifiaction in 574 Respiratory cases, 431 Non-respiratory cases, and 334 Screened cases. The analysis showed a significant difference in survival time between R cases, NR cases and S cases, with estimated median survival times of 12 years, 14 years and 16 years, respectively (p < 0.001).

Back to article page